Navigation Links
S*BIO Initiates U.S. Phase I Clinical Trials of Oral JAK2 Inhibitor SB1518 for the Treatment of Hematological Malignancies
Date:9/17/2008

SINGAPORE, Sept. 18 /PRNewswire/ -- S*BIO Pte Ltd today announced the initiation of multi-center Phase I clinical trials of SB1518, a potent and orally-active JAK2 inhibitor, in patients with leukemia and certain types of lymphoma. These first Phase I trials for SB1518 comprise of ascending dose studies conducted at several leading clinical sites in the United States. The trials are expected to enroll up to 60 patients and are designed to determine the maximum tolerated dose and to assess the pharmacokinetics and overall safety profile of SB1518.

SB1518 is a small molecule JAK2-selective kinase inhibitor which has high potency against both the wild-type JAK2 kinase and the JAK2 kinase with the V617F mutation. The V617F mutation is found in high frequencies in various myeloproliferative disorders such as idiopathic myelofibrosis. SB1518 might also provide an effective treatment for other hematological malignancies with mutations and re-arrangements in the JAK2 gene.

"The entry of SB1518 into the clinical phase marks an important milestone for S*BIO and potentially offers a new targeted therapy for this group of difficult-to-treat patients that represent a significant unmet medical need," said Dr. Jan-Anders Karlsson, CEO of S*BIO. "SB1518 has demonstrated exciting anti-proliferative and anti-tumor activity, combined with excellent tolerability in relevant in vitro and in vivo models. We are pleased to conduct our company's first clinical trials in the United States at well respected centers such as The University of Texas M.D. Anderson Cancer Center, the University of Chicago Medical Center and the Fred Hutchinson Cancer Research Center."

In addition to SB1518, S*BIO has a robust pipeline including SB939, the company's lead histone deacetylase (HDAC) inhibitor, which is currently in Phase I trials in Singapore and Canada. S*BIO's target-driven approach to developing innovative small molecule therapies for cancer is built on a profound unde
'/>"/>

SOURCE S*BIO Pte Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. S*BIO to Develop New JAK-2 Inhibitor for Treatment of Myeloproliferative Disorders and Hematological Malignancies
2. Enanta Initiates Phase 1 Study on EDP-322, an Oral Antibiotic With Activity Against Hospital- and Community-Acquired MRSA
3. QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome
4. Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections
5. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
6. Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing
7. Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia
8. Isis Initiates Clinical Trial of CRP Drug
9. Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial
10. Aegera Initiates a Fifth Phase 1 and 2 Clinical Trial for AEG35156
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... TAIPEI , Sept. 1, 2015 ... (GNTbm) held a press conference in Taipei ... developments in its new Vaucarrin™ platform, a targeted drug ... vehicle. This event was part of a ... Gold NanoTech Inc. (GNT), showcasing GNT,s latest ...
(Date:9/1/2015)... Sept. 1, 2015 Sargas Pharmaceutical Adherence ... and Drug Adherence m Health applications along with ... process of non face-to-face monitoring of twenty minutes ... release of our apps, doctors are now well ... with our ONCHIT certified Physician, Pharmacy and Patient ...
(Date:9/1/2015)... -- Agena Bioscience TM today announced the establishment of ... and financial hub from which many biotech and life science ... mainland China . "The Chinese ... with almost sixty MassARRAY ® Systems installed to date. ... us to expand our reach and foster a high degree ...
Breaking Medicine Technology:GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 3GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 4GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 5SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2Agena Bioscience Opens Office in Shanghai, China 2
... 12 Research presented at the American College of ... that an intervention to reduce over-dispensing and waste of ... can result in substantial cost savings. , Medco Health ... of a study that examined the effectiveness and safety ...
... 12 /PRNewswire / -- New research findings ... (SIO) Sixth International Conference in New York show ... complementary and alternative medicine (CAM) using traditional research ... Children,s Hospitals and Clinics of Minnesota (Children,s), presented ...
Cached Medicine Technology:New Research Shows Over-use of Asthma Rescue Inhalers Substantially Reduced Through Pharmacist-initiated Physician Intervention 2New Research Shows Over-use of Asthma Rescue Inhalers Substantially Reduced Through Pharmacist-initiated Physician Intervention 3New Research Shows Promise in Using Traditional Research Methods to Assess Efficacy of Complementary Therapies 2
(Date:9/1/2015)... ... September 01, 2015 , ... In an article ... across the country are switching from traditional dental impressions to digital impressions using ... Dr. Sam Saleh of Ora Dentistry Spa, his practice has been an early ...
(Date:9/1/2015)... ... 2015 , ... Earth Brands, ( http://www.earthbrands.com ) a comfort-meets-fashion ... who buys an Earth Brand shoe will be given an opportunity to plant ... Future, a nonprofit dedicated to planting more trees. Earth Brands products represent contemporary ...
(Date:9/1/2015)... ... 01, 2015 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... awareness initiative, the nation’s premier and most high-profile lymphoma awareness campaign. Since its ...
(Date:9/1/2015)... Bronx, NY (PRWEB) , ... September 01, 2015 , ... ... for 86 children and teenagers, from ages 6-18. Calvary’s Camp Compass® has taken place ... camp staff included 65 adult counselors, some of whom work for Calvary, and two ...
(Date:9/1/2015)... ... , ... Georgia State University and its partners have introduced ... sexual assaults on their campuses. , The free, evidence-based survey was developed by ... and student affairs professionals responding to calls by the Obama Administration to strengthen ...
Breaking Medicine News(10 mins):Health News:Article on CAD/CAM Dental Technology Highlights the Advantages of 21st Century Dentistry, Notes Ora Dentistry Spa 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 2Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Georgia State, Partners Introduce Climate Survey to Aid in Preventing Campus Sexual Assaults 2
... Record revenues of $92.4 million , -- Record non-infant formula ... of $17.1 million , -- Earnings per share of $0.33, an ... Operating cash flow of $17 million (Year-to-date operating cash flow of ... $1.20 - $1.25 per share, pre-tax earnings growth of 10% ...
... ... eliminate communication breakdowns that contribute to delays in care and clinical decision-making, Fauquier Hospital ... nurses 15-25 minutes per shift. , ... Knoxville, TN (PRWEB) June 3, 2009 -- In an effort to ...
... Lauded in Healthcare Category for ,Visionary Application of Information ... , , MADISON, N.J., June 3 ... world,s leading provider of diagnostic testing, information and services, ... Ltd. has been recognized as a Laureate by the ...
... Georgia graduate program in special education that has prepared ... with autism over the last several years has received ... to work with similarly challenged secondary-age students. Autism ... a group known as autism spectrum disorders (ASD). ...
... rise in countries such as Australia and Chile; mortality ... -- With more cases of the H1N1 swine flu ... the World Health Organization is weighing whether to declare ... infections and deaths have occurred in Mexico (the source ...
... Specialist Uncovers Alternatives To Back Surgery And Other Traditional Medical Treatments ... is the host of the new radio show in Los Angeles, "The ... KRLA (870 on AM Dial) and the main topic focuses on new ... is the Director of the Herniated Disc & Back Pain Clinic in ...
Cached Medicine News:Health News:Martek Announces Second Quarter 2009 Financial Results 2Health News:Martek Announces Second Quarter 2009 Financial Results 3Health News:Martek Announces Second Quarter 2009 Financial Results 4Health News:Martek Announces Second Quarter 2009 Financial Results 5Health News:Martek Announces Second Quarter 2009 Financial Results 6Health News:Martek Announces Second Quarter 2009 Financial Results 7Health News:Martek Announces Second Quarter 2009 Financial Results 8Health News:Martek Announces Second Quarter 2009 Financial Results 9Health News:Martek Announces Second Quarter 2009 Financial Results 10Health News:Martek Announces Second Quarter 2009 Financial Results 11Health News:Martek Announces Second Quarter 2009 Financial Results 12Health News:Fauquier Hospital Nurses Increasing Productivity by 15-25 Minutes per Shift with PerfectServe 2Health News:Quest Diagnostics India Recognized as Laureate by the Computerworld Honors Program 2Health News:Quest Diagnostics India Recognized as Laureate by the Computerworld Honors Program 3Health News:Quest Diagnostics India Recognized as Laureate by the Computerworld Honors Program 4Health News:UGA grad program expands to prepare teachers to work with secondary students with autism 2Health News:UGA grad program expands to prepare teachers to work with secondary students with autism 3Health News:WHO Close to Declaring Swine Flu Pandemic 2Health News:WHO Close to Declaring Swine Flu Pandemic 3Health News:WHO Close to Declaring Swine Flu Pandemic 4Health News:WHO Close to Declaring Swine Flu Pandemic 5Health News:WHO Close to Declaring Swine Flu Pandemic 6Health News:WHO Close to Declaring Swine Flu Pandemic 7Health News:WHO Close to Declaring Swine Flu Pandemic 8Health News:WHO Close to Declaring Swine Flu Pandemic 9Health News:WHO Close to Declaring Swine Flu Pandemic 10Health News:WHO Close to Declaring Swine Flu Pandemic 11Health News:Dr. Edward Martin Hosts New Los Angeles Radio Show About Back Pain 2
Straight shafts with 0.12 mm teeth and tying platform. Serrated handle with polished finish....
Angled 45 degree shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Heavy curved shafts with 2 x 2 teeth and crisscross serrated 6 mm tying platform. Serrated handle with polished finish....
Straight shafts with 1 x 2 teeth and 6 mm tying platform. Wide serrated handle with polished finish....
Medicine Products: